Literature DB >> 21415759

Natural history of Danon disease.

Dana Boucek1, Jean Jirikowic, Matthew Taylor.   

Abstract

BACKGROUND: Danon disease is a rare but serious cardiac and skeletal myopathy leading to substantial morbidity and early mortality due to arrhythmia and cardiomyopathy. The X-linked nature of inheritance accounts for reported differences in phenotypic severity between men and women. The rarity of Danon disease has limited understanding of the complete phenotype. Clinical estimates of ages of disease onset and survival based on gender have not been published. METHODS AND
RESULTS: We present data on 82 patients with Danon disease from 36 families, the largest series to date. Men were severely affected with cognitive disabilities (100%), hypertrophic cardiomyopathy (88%), and muscle weakness (80%). Men had a high morbidity and were unlikely to reach the age of 25 years without a cardiac transplantation. Women were less severely affected but reported higher than expected levels of cognitive (47%) and skeletal muscle complaints (50%) and manifesting an equal prevalence of dilated cardiomyopathy and hypertrophic cardiomyopathy. Combining our data with that of 63 other Danon disease case reports in the literature, the average ages of first symptom, cardiac transplantation, and death were 12.1, 17.9, and 19.0 years in men and 27.9, 33.7, and 34.6 years in women, respectively.
CONCLUSION: These data more broadly illuminate the Danon disease phenotype and should prove useful to physicians working with and providing genetic counseling to families with Danon disease. Women with Danon disease present with clinical symptoms and events approximately 15 years after men and report a higher proportion of cognitive and skeletal muscle problems than previously recognized.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415759     DOI: 10.1097/GIM.0b013e31820ad795

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  52 in total

Review 1.  The Role of Genetics in Peripartum Cardiomyopathy.

Authors:  Yi Zhen Joan Lee; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2017-08-03       Impact factor: 4.132

Review 2.  Clinical Spectrum of PRKAG2 Syndrome.

Authors:  Andrea Giuseppe Porto; Francesca Brun; Giovanni Maria Severini; Pasquale Losurdo; Enrico Fabris; Matthew R G Taylor; Luisa Mestroni; Gianfranco Sinagra
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-01

Review 3.  Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.

Authors:  Toru Kubo; Hiroaki Kitaoka
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

4.  Danon Disease Due to a Novel LAMP2 Microduplication.

Authors:  Matthew A Lines; Stacy Hewson; William Halliday; Peter J B Sabatini; Tracy Stockley; Anne I Dipchand; Sarah Bowdin; Komudi Siriwardena
Journal:  JIMD Rep       Date:  2013-11-13

5.  Asymptomatic young man with Danon disease.

Authors:  Jiwon Kim; Parag Parikh; Mohammad Mahboob; James A Arrighi; Michael K Atalay; Ethan J Rowin; Martin S Maron
Journal:  Tex Heart Inst J       Date:  2014-06-01

Review 6.  Danon disease - dysregulation of autophagy in a multisystem disorder with cardiomyopathy.

Authors:  Teisha J Rowland; Mary E Sweet; Luisa Mestroni; Matthew R G Taylor
Journal:  J Cell Sci       Date:  2016-05-10       Impact factor: 5.285

7.  MMP9 inhibition increases autophagic flux in chronic heart failure.

Authors:  Shyam S Nandi; Kenichi Katsurada; Neeru M Sharma; Daniel R Anderson; Sushil K Mahata; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-16       Impact factor: 4.733

8.  Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure.

Authors:  Sherin I Hashem; Cynthia N Perry; Matthieu Bauer; Sangyoon Han; Stacey D Clegg; Kunfu Ouyang; Dekker C Deacon; Mary Spinharney; Athanasia D Panopoulos; Juan Carlos Izpisua Belmonte; Kelly A Frazer; Ju Chen; Qiuming Gong; Zhengfeng Zhou; Neil C Chi; Eric D Adler
Journal:  Stem Cells       Date:  2015-05-13       Impact factor: 6.277

9.  Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation).

Authors:  Maya Yardeni; Omri Weisman; Hanna Mandel; Ronnie Weinberger; Giovanni Quarta; Joel Salazar-Mendiguchía; Pablo Garcia-Pavia; Maria José Lobato-Rodríguez; Lourdes Fajardo Simon; Freimark Dov; Michael Arad; Doron Gothelf
Journal:  Am J Med Genet A       Date:  2017-06-19       Impact factor: 2.802

10.  Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics.

Authors:  Filip Majer; Ondrej Pelak; Tomas Kalina; Hana Vlaskova; Lenka Dvorakova; Tomas Honzik; Tomas Palecek; Petr Kuchynka; Martin Masek; Jiri Zeman; Milan Elleder; Jakub Sikora
Journal:  J Inherit Metab Dis       Date:  2013-05-29       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.